Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 7, Issue 12 (2018)

A study on complications of diabetes mellitus type 2 and its clinical manifestations in a community setup

Author(s):
Snehitha Reddy Bhimavarapu, Lahari Reddy Gaddam, Jyothika Chowdary Suryadevara, Narender Boggula and R Srinivasan
Abstract:
Background: Diabetes is the leading cause of morbidity and mortality worldwide and the major causes for the mortality are due to complications of diabetes and it is predicted that by 2025 the number of people suffering from diabetes will increase to 190 Million. Indians are susceptible to premature onset of DM which intern lead to rapid progression of chronic vascular complications, incurring heavy burden on health care systems on India. In India majority of patients were unaware of complications occurs due to diabetes. Thus it is very important to provide the information on prevalence of complications of diabetes to patient and physician to control mortality rate due to it.
Objectives: This study was intended to obtain information on prevalence of diabetic complications in a community setup and to provide patient counselling on the same which may help to improve their overall quality of life.
Methodology: A prospective observational study was carried in and around the area of the Bengaluru through a series of a health camp. The tentative duration of the study was 6 months. Free health camps were conducted and screening of the blood glucose was provided. Data was collect based on demographic details, past and present medical history was collected in a specially designed profile forms. Individual patient counselling was provided to each participant in the language of their comfort. Feedback was collected from the participants regarding their satisfaction towards the camp and also suggestions given by then were noted as well as suitable areas of improvements which may help us to provide better service to the patient. All information leaflets containing brief information on diabetes with pictorial representation were provided and explained to the each participant in both English and Kannada.
Results: A total of 319 subjects were enrolled in the study through a series of 3 health camps, out of which are suffering from diabetes, are suffering from both diabetes and hypertension, and subjects were not diagnosed with any complications. Prevalence percentage of complications for particular factor was calculated. Prevalence percentages in diabetic subjects were also performed relative risk to know the presence of any significant relationship between complications and their particular factor (diabetes). The relative risk values for diabetes complications are for memory impairment, for CHD, for retinopathy, for cataract and for neuropathy. All values of relative risk are more than 1 and which showed that there was a significant relationship between complications and their associated factor and was then conformed by conducting chi-square tests for each complication individually and the resulted P-value showed that all complications were significantly related to disease except for retinopathy with a P-value of which doesn’t shows significant relationship with the factor diabetes in our study.
Conclusion: Hence we observed higher prevalence percentage of memory impairment in diabetes and also diabetic complications were higher among all the diabetic individuals. All the diabetic complications observed need to be observed in prevention and control strategies in the study area. Also, community awareness programs need to be implemented to percolate the knowledge about the diabetic complications, the available screening facilities for their early detection treatment and care.
Pages: 257-260  |  325 Views  12 Downloads
How to cite this article:
Snehitha Reddy Bhimavarapu, Lahari Reddy Gaddam, Jyothika Chowdary Suryadevara, Narender Boggula, R Srinivasan. A study on complications of diabetes mellitus type 2 and its clinical manifestations in a community setup. Pharma Innovation 2018;7(12):257-260.
The Pharma Innovation Journal